DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

RPG Life Sciences Limited — Press Release

NSE 51 min ago·2 Sept 2026, 4:53 pm

RPG Life Sciences

RPG Life Sciences Limited has announced a press release regarding a significant development. The company has disclosed information that investors need to be aware of, though the specific details of the announcement have not been fully detailed in the provided headline.

This news is important for RPGLIFE shareholders as it signals a material update that could impact the company's future performance. Investors should pay close attention to the full press release to understand the nature of the announcement and its potential implications for the stock.

Moving forward, the market will be watching for further clarification on the details of the press release. Investors should monitor the stock's reaction and any subsequent comments from the company to gauge the significance of this update.